"Beauty" Month News | Viewing Industry Development from Industry Trends


Release Time:

Jun 26,2025

In May, Yang Zhimin, deputy director of the Center for Drug Evaluation of the National Medical Products Administration, and his team visited the Lecheng Pilot Zone to investigate the real-world research on drugs and held a symposium. During this period, Yidu Cloud, as the construction enterprise of the real-world data research platform in Hainan Province, demonstrated the functions of the platform.

"Beautiful" Month News

The National Medical Products Administration has conducted a survey on real-world research on drugs

In May, Yang Zhimin, deputy director of the Center for Drug Evaluation of the National Medical Products Administration, and his team visited the Lecheng Pilot Zone to investigate the real-world research on drugs and held a symposium. During this period, Yidu Cloud, as the construction enterprise of the real-world data research platform in Hainan Province, demonstrated the functions of the platform. The experts of the research team visited the Boao Super Hospital and the Hainan Real-world Data Research Institute to conduct on-site inspections of the operation of the clinical real-world data research platform in Hainan Province, and held a special symposium on the real-world research of drugs in Lecheng.

The theme activity of "Safe Makeup Use, Rule of Law Together" was launched

From May 24th to 27th, drug regulatory authorities at all levels in the Inner Mongolia Autonomous Region held a series of promotional activities for the "International Skin Care Day" on May 25th with the theme of "Safe Makeup Use, Legal Action Together". At the event site, through various forms such as setting up display boards, distributing promotional materials, conducting free medical consultations and providing advice, the relevant knowledge of safe use of cosmetics and the concept of scientific skin care were popularized among the general public, thereby guiding the public to shape correct consumption concepts. At the same time, it also carried out focused publicity on children's cosmetics, special cosmetics, etc., to enhance the public's awareness and understanding of cosmetics.

Leaders of the National Medical Products Administration conducted research in Beijing

On May 14th, Xu Jinghe, a member of the Party Group and Vice minister of the National Medical Products Administration, conducted a research on the implementation status of the "Regulations on the Supervision and Administration of Cosmetics" in Beijing. He personally visited some cosmetics and toothpaste manufacturing enterprises on the spot to understand the demands for high-quality development of industrial innovation. At the same time, a symposium was held with local drug regulatory authorities, research institutes, industry associations and enterprise representatives to discuss and exchange views on promoting the legal system construction of cosmetics supervision.

The Supervision Bureau of Guangzhou City has issued new regulations

On May 15th, the Guangzhou Market Supervision and Administration Bureau issued the "Q&A on the Filing of Ordinary Cosmetics (Issue 59)". This Q&A provides answers to many questions, including the meaning of archiving cosmetic safety assessment reports for future reference, the applicable criteria for safety testing of cosmetic final products, and how to select the test items for safety testing of cosmetic final products. Regarding the question of "How to determine if the content of raw materials is' low '", the Guangzhou Market Supervision and Administration Bureau stated that given the significant differences in the structure and function of different raw materials, for instance, raw materials that play a role in the product in the formula, when their usage concentration is 0.1%, may have almost no impact on the human body and pose a relatively low safety risk.

"RGD amideated hyaluronic acid" has completed the filing

On May 14th, it was shown on the new cosmetic ingredient filing information platform of the National Medical Products Administration that the "RGD Aminated Hyaluronic acid" of Shaanxi Baihong Synthetic Biotechnology Co., LTD., a subsidiary of Baihong Group, successfully completed the filing, and its filing number is "Guozhuang Yuanbei Zi 20240033". It is reported that this "RGD amideated hyaluronic acid" is a raw material with highly efficient moisturizing and long-lasting water-locking effects. It can be applied in various formulas such as water-based products, essences, lotions, creams, and cleansers, and has good compatibility. At present, the technical requirements for this new raw material have not been made public yet.

The China Securities Regulatory Commission requested MAO Geping to provide additional materials

On May 10th, a public notice on the requirements for supplementary materials for the filing of overseas issuance and listing was released on the official website of the China Securities Regulatory Commission. Among them, the China Securities Regulatory Commission has put forward five points that need to be supplemented and explained to Maogeping Company. The first one is the changes in the company's shares since the beginning of 2024. The second is the specific status of the products such as websites, apps and mini-programs developed and operated by the company; The third is the rationality of the company's dividends during the reporting period and the compliance of the internal decision-making procedures; The fourth point is whether the shares held by the shareholders who intend to participate in the "full circulation" are subject to pledge, freezing or other controversial circumstances; The fifth point is the relevant circumstances of having applied for A-share listing before, as well as whether there are any matters that will have A significant impact on this issuance and listing. It is understood that on April 8th, MAO Geping officially submitted an application for listing on the main board of the Hong Kong Stock Exchange.

Guangzhou will carry out the quality improvement work for cosmetic manufacturing enterprises

Not long ago, the Guangzhou Market Supervision and Administration Bureau issued a notice on organizing and launching the first batch of quality improvement work for cosmetic manufacturing enterprises. This time, the quality improvement work for cosmetics manufacturing enterprises will focus on the production enterprises of high-risk products such as hair dyeing, freckling and whitening, sun protection masks, children's products and eye products. The assistance will be implemented through three steps: providing technical services respectively, formulating assistance plans and putting forward assessment opinions. At present, the Guangzhou Market Supervision and Administration Bureau has selected 30 enterprises within the city as the first batch of quality improvement assistance targets.


Related Blog


New product release

In November, a certain beauty brand launched a limited-edition new product, the Gold Powder cushion. Its shell design is inspired by the future aesthetics and cyber gold elements of Y3K. It also offers a dual-core option and a dual-formula detailed makeup effect, providing consumers with a variety of base makeup choices.

Jun 26,2025

"Us" monthly financial report

On May 30th, Ulta Beauty, the largest beauty retailer in the United States, released its Q1 financial report for fiscal year 2024. Data shows that in the first quarter, Ulta's net sales reached 2.725 billion US dollars (approximately 19.732 billion yuan), representing a year-on-year increase of 3.5%. Ulta stated that the growth in net sales was mainly attributed to the increase in comparable sales, contributions from new stores, and growth in other revenues.

Jun 26,2025

Beauty Industry Insights: Insights into Industry Development through Data

The Beijing Municipal Drug Administration has released the "Q&A on Common Questions regarding the Filing of Ordinary Cosmetics (Issue 31)", providing answers to a series of questions related to the filing of children's cosmetics.

Jun 26,2025